Table 3

Summary of the findings of the literature in local injections of anti-TNF agents in perianal fistulas in CD

AuthorYearType of agentPatients (n)Fistula closureFistula partial response
Poggioli G et al 48 2005IFX1566.7% (10/15)
Asteria et al 49 2006IFX1136.4% (4/11)72.7% (8/11)
Alessandroni et al 15 2011IFX12 (4 excluded)87.5% (7/8)
Tonelli et al 50 2013ADA1275% (9/12)25% (3/12)
  • ADA, adalimumab; IFX , infliximab.